M. D. Anderson Cancer Center - News Releases

M. D. Anderson's Head of Women Faculty Programs, Elizabeth Travis, Receives 2009 AAMC Women in Medicine Leadership Development Award

2009-11-10T20:19:24Z

Elizabeth Travis, Ph.D., associate vice president for Women Faculty Programs and professor in the Departments of Experimental Radiation Oncology and Pulmonary Medicine at The University of Texas M. D. Anderson Cancer Center, has received the 2009 Association of American Medical Colleges (AAMC) Women in Medicine Leadership Development Award.

M. D. Anderson Chief Nursing Officer Named AAN Fellow

2009-11-10T14:19:25Z

The University of Texas M. D. Anderson Cancer Center's top nursing executive has been recognized with nursing's highest honor.

Green Tea Shows Promise as Chemoprevention Agent for Oral Cancer, M. D. Anderson Study Finds

2009-11-05T13:28:37Z

Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center.

Early Stage, HER2 Positive Breast Cancer Patients at Increased Risk of Recurrence

2009-11-02T21:45:40Z

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

Academic Pressures and Stress Take Toll on Scientists, Clinicians

2009-11-02T16:43:02Z

On average, research shows, the United States loses the equivalent of at least one entire medical school class each year to suicide- as many as 400 physicians. The book Faculty Health in Academic Medicine: Scientists, Physicians, and the Pressures of Success (Humana Press/Springer), by faculty at The University of Texas M. D. Anderson Cancer Center and other national medical experts, breaks new ground in a first-of-its-kind look at faculty health.

Th17 Cells Summon an Immune System Strike Against Cancer

2009-10-29T20:25:10Z

A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson Cancer Center report in the early online edition of the journal Immunity.

NIH Awards M. D. Anderson 84 Research Grants from Stimulus Funds

2009-10-28T15:37:50Z

Researchers at The University of Texas M. D. Anderson Cancer Center have been awarded 84 grants through the American Recovery and Reinvestment Act (ARRA) of 2009, including 10 earned under two highly competitive programs to rapidly advance cancer research over two years.

M. D. Anderson's Lois Ramondetta Recognized for Excellence in Patient Care

2009-10-20T21:18:03Z

Lois M. Ramondetta, M.D., associate professor in the Department of Gynecologic Oncology at The University of Texas M. D. Anderson Cancer Center, is the recipient of the 2009 Julie and Ben Rogers Award for Excellence in Patient Care.

Study Finds No Relationship Between PCR Rate and Race in Women with Breast Cancer

2009-10-09T21:31:19Z

Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.

KEAP1 Keeps Major Cancer-Promoting Protein at Bay

2009-10-09T20:00:14Z

A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.

M. D. Anderson Team Chosen to Help Navigate Cancer Genome AtlasM. D. Anderson Team Chosen to Help Navigate Cancer Genome Atlas

2009-10-07T17:59:59Z

The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.

Stereotactic Radiosurgery Preferred Method of Treating Cancer Patients with Brain Metastases

2009-10-06T19:12:41Z

Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to researchers at The University of Texas M. D. Anderson Cancer Center.

M. D. Anderson Patient Shares Experience and Advice

2009-10-02T17:52:33Z

Mark Stratmann has always enjoyed the outdoors, riding motorcycles and traveling, but as a two-year survivor of a rare cancer called mesothelioma, these hobbies are now more important than ever. They remind him to enjoy life and encourage other patients to seek treatment at a cancer center with a team of specialists dedicated to this disease.

Lung Cancer Suppresses miR-200 to Invade and Spread

2009-09-15T14:55:33Z

Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report in the Sept. 15 edition of Genes and Development.

Overexpressed Protein Converts Noninvasive Breast Cancer into Invasive Disease

2009-09-08T18:27:36Z

Active, but non-invasive breast cancer is set free to roam as invasive breast cancer when an overexpressed protein converts it to a different cell type, scientists at The University of Texas M. D. Anderson Cancer Center report in the Sept. 9 issue of the journal Cancer Cell.